Publication | Closed Access

LCZ696 (Sacubitril/Valsartan), an Angiotensin-Receptor Neprilysin Inhibitor, Attenuates Cardiac Hypertrophy, Fibrosis, and Vasculopathy in a Rat Model of Chronic Kidney Disease

HypertensionRenal FunctionKidney ResearchMedicinePhysiologyChronic Kidney DiseaseRat ModelVascular BiologyPharmacologyNephrologyAngiotensin-receptor Neprilysin Inhibitor